エレクトロシューティカル／生体電気医学市場 : 2029年までの世界予測

Report Overview

The global market for electroceuticals/bioelectric medicine is expected to grow to USD 33.6 billion by 2029, up from USD 23.9 billion in 2024, representing a CAGR of 7.0% during the forecast period.

エレクトロシューティカル／生体電気医学市場の世界市場は、2024年の239億米ドルから2029年までに336億米ドルに成長すると予想されており、予測期間中のCAGRは7.0%に相当します。

This growth is being primarily driven by several factors, including increased investments and funding for research on cardiac rhythm management (CRM) devices, rising government support and funding for neurological disorders, and the growing geriatric population, which is leading to a higher prevalence of neurological and cardiovascular disorders. However, the market’s growth is being hindered by the high cost of electroceutical devices and the need for significant capital investments.

“The retinal implants segment accounted for the highest growth rate in the electroceuticals market, by product, during the forecast period”
Based on product, the electroceuticals market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, neuromodulators, cochlear implants, and retinal implants. In 2022, the retinal implants segment accounted for the highest growth rate in the electroceuticals market. The main driving factor for retinal implants is the potential to restore vision in individuals with retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration.

“The non-invasive electroceuticals devices segment is projected to experience the highest revenue growth rate during the forecast period” 
The electroceuticals market is divided into two segments: implantable electroceutical devices and non-invasive electroceutical devices. In 2022, the noninvasive electroceutical devices segment experienced the highest growth rate. These devices do not require surgical implantation; instead, they use electrical or magnetic fields to stimulate nerves or muscles on the body’s surface. They are easy to use, cost-effective, and carry a lower risk of infection. Non-invasive electroceuticals are increasingly being used in the treatment of chronic pain, neurological disorders, and metabolic disorders. Technological advancements in non-invasive electroceuticals, along with increased healthcare expenditure and a rise in the prevalence of chronic diseases, are anticipated to drive the growth of the non-invasive devices segment in the forecast period.

“Asia Pacific: The fastest-growing region in electroceuticals care market”
The global electroceuticals market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to record the highest CAGR during the forecast period. This growth is attributed to factors such as increased healthcare expenditure, rising pharmaceutical research funding, government initiatives to raise awareness about early disease detection, expansion of private-sector hospitals into rural areas in various APAC countries, and the presence of high-growth markets in the region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 28%, Tier 2 – 42%, and Tier 3 -30%
• By Designation: C-level – 30%, D-level – 34%, and Others – 36%
• By Region: North America – 46%, Europe – 25%, Asia Pacific – 18%, and Rest of the World -11%

Lists of Companies Profiled in the Report:
• Medtronic plc (Ireland)
• Boston Scientific Corporation (US)
• Abbott Laboratories, Inc. (US)
• Cochlear Ltd. (Australia)
• LivaNova PLC (UK)
• MicroPort Scientific Corporation (China)
• Sonova Group (Switzerland)
• Nevro Corp. (US)
• Axonics Modulation Technologies, Inc. (US)
• Neuronetics, Inc. (US)
• ElectroCore, Inc. (US)
• NeuroPace, Inc. (US)
• BIOTRONIK (Germany)
• Medico S.p.A. (Italy)
• Nurotron Biotechnology Co. Ltd. (US)
• MED-EL (Austria)
• Aleva Neurotherapeutics SA (Switzerland)
• NeuroSigma, Inc. (US)
• BioWave Corporation (US)
• Soterix Medical Inc. (US)
• Bioinduction (Amber Therapeutics) (UK)
• GiMer Medical (Taiwan)
• Cefaly (Belgium)
• BioControl Medical (Israel)
• tVNS Technologies GmbH (Germany).

Research Coverage:
This research report categorizes the electroceuticals market by products, type, application and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the electroceuticals market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies; contracts, partnerships, agreements, new product launches, mergers and acquisitions, and recent developments associated with the electroceuticals market. Competitive analysis of upcoming startups in the electroceuticals market ecosystem is covered in this report.   
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall electroceuticals market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.  

The report provides insights on the following pointers:
• Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the electroceuticals market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the electroceuticals market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the electroceuticals market across varied regions.    
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the electroceuticals market.
• Competitive Assessment: In-depth assessment of market ranking, growth strategies and product offerings of leading players like Medtronic plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories, Inc. (US), and Cochlear Ltd. (Australia) among others in the electroceuticals market strategies. 

Table of Contents

1            INTRODUCTION            53

1.1         STUDY OBJECTIVES      53

1.2         MARKET DEFINITION   53

1.2.1      INCLUSIONS & EXCLUSIONS OF STUDY 54

1.3         STUDY SCOPE  54

FIGURE 1           ELECTROCEUTICALS MARKET SEGMENTATION            54

1.3.1      GEOGRAPHIC SCOPE    55

1.3.2      YEARS CONSIDERED     55

1.4         CURRENCY        56

1.5         LIMITATIONS   56

1.6         STAKEHOLDERS            56

1.7         SUMMARY OF CHANGES            57

1.7.1      RECESSION IMPACT      57

2            RESEARCH METHODOLOGY     58

2.1         RESEARCH DATA           58

FIGURE 2           RESEARCH DESIGN       58

2.1.1      SECONDARY DATA       59

2.1.1.1   Key data from secondary sources     59

2.1.2      PRIMARY DATA 60

2.1.2.1   Key data from primary sources         61

2.1.2.2   Key industry insights          62

TABLE 1             BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 62

FIGURE 3           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    63

FIGURE 4           BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION    63

2.2         MARKET SIZE ESTIMATION       64

2.2.1      BOTTOM-UP APPROACH           64

FIGURE 5           MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (COMPANY REVENUE ESTIMATION APPROACH)            64

FIGURE 6           MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (SEGMENTAL REVENUE ESTIMATION APPROACH)        65

FIGURE 7           MARKET SIZE ESTIMATION: TOP-DOWN APPROACH    66

FIGURE 8           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   66

2.3         MARKET BREAKDOWN & DATA TRIANGULATION          67

FIGURE 9           DATA TRIANGULATION METHODOLOGY         67

2.4         MARKET SHARE ANALYSIS         68

2.5         ASSUMPTIONS 68

2.6         RISK ASSESSMENT         68

TABLE 2             RISK ASSESSMENT: ELECTROCEUTICALS MARKET         68

2.7         LIMITATIONS   69

2.7.1      METHODOLOGY-RELATED LIMITATIONS         69

2.7.2      SCOPE-RELATED LIMITATIONS             69

2.8         IMPACT OF RECESSION ON ELECTROCEUTICALS MARKET        69

3            EXECUTIVE SUMMARY 70

FIGURE 10         ELECTROCEUTICALS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 70

FIGURE 11         ELECTROCEUTICALS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)          71

FIGURE 12         ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2024 VS. 2029 (USD MILLION)     71

FIGURE 13         ELECTROCEUTICALS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)          72

4            PREMIUM INSIGHTS      73

4.1         ELECTROCEUTICALS MARKET OVERVIEW         73

FIGURE 14         RISING PREVALENCE OF NEUROLOGICAL AND CARDIOVASCULAR DISORDERS TO DRIVE MARKET      73

4.2         ELECTROCEUTICALS MARKET SHARE, BY PRODUCT, 2024 VS. 2029              74

FIGURE 15         CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS WILL CONTINUE TO DOMINATE MARKET IN 2029     74

4.3         ELECTROCEUTICALS MARKET SHARE, BY TYPE, 2024 VS. 2029   74

FIGURE 16         IMPLANTABLE ELECTROCEUTICAL DEVICES TO DOMINATE MARKET IN 2024             74

4.4         ELECTROCEUTICALS MARKET SHARE FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2024 VS. 2029      75

FIGURE 17         ARRHYTHMIA SEGMENT TO DOMINATE MARKET IN 2029              75

4.5         ELECTROCEUTICALS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           75

FIGURE 18         ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN ELECTROCEUTICALS MARKET DURING FORECAST PERIOD      75

5            MARKET OVERVIEW     76

5.1         INTRODUCTION            76

5.2         MARKET DYNAMICS     76

FIGURE 19         ELECTROCEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    76

5.2.1      DRIVERS            77

5.2.1.1   Rising geriatric population and subsequent growth in prevalence of neurological and cardiovascular disorders            77

5.2.1.2   Rising government support and funding for neurological disorders          78

5.2.1.3   Increasing investments and funding for research on CRM devices            78

5.2.1.4   Increasing focus on development of advanced neuromodulation and cardiac devices   79

5.2.1.5   Increasing collaborations among device manufacturers, healthcare providers, and research institutes to develop neuromodulation and cardiac devices         79

5.2.1.6   Availability of reimbursements for neuromodulation, cardiac devices, and cochlear implants 80

5.2.1.7   Growing prevalence of hearing loss and increasing adoption of smart hearing aids              80

5.2.2      RESTRAINTS     81

5.2.2.1   High cost of electroceutical devices  81

5.2.2.2   Preference for drug therapies over neuromodulation and cardiac products              81

5.2.2.3   Adverse effects and complications associated with neuromodulation, cardiac devices, and cochlear implants         81

TABLE 3             POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH DIFFERENT DEVICES    82

5.2.3      OPPORTUNITIES           82

5.2.3.1   Emerging markets              82

5.2.3.2   Development of ICDs and MRI-compatible ICDs and CRT-Ds 83

5.2.3.3   Integration with digital health platforms        83

5.2.4      CHALLENGES   84

5.2.4.1   Dearth of trained professionals        84

5.2.4.2   Challenges associated with battery life and device replacement  84

5.2.4.3   Complexity and infection issues related to electroceutical devices            85

5.2.5      TRENDS             85

5.2.5.1   Role of artificial intelligence (AI) in electroceutical devices        85

5.2.5.2   Wearable and portable electroceuticals          86

5.3         PRICING ANALYSIS        86

TABLE 4             AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022)           86

TABLE 5             AVERAGE SELLING PRICE TREND FOR NEUROMODULATION DEVICES AND PROCEDURES, BY REGION (2022)             86

5.4         VALUE CHAIN ANALYSIS            87

FIGURE 20         VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES      87

5.5         SUPPLY CHAIN ANALYSIS          88

FIGURE 21         DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES          89

5.6         ECOSYSTEM ANALYSIS OF ELECTROCEUTICALS MARKET          89

FIGURE 22         ELECTROCEUTICALS MARKET: ECOSYSTEM ANALYSIS 89

5.6.1      ROLE IN ECOSYSTEM    90

TABLE 6             ELECTROCEUTICALS MARKET: ROLE IN ECOSYSTEM   90

5.6.2      KEY PLAYERS IN ELECTROCEUTICALS MARKET             90

FIGURE 23         ELECTROCEUTICALS MARKET: KEY PLAYERS   90

5.7         PORTER’S FIVE FORCES ANALYSIS         91

TABLE 7             ELECTROCEUTICALS MARKET: PORTER’S FIVE FORCES ANALYSIS          91

5.7.1      THREAT OF NEW ENTRANTS    91

5.7.2      INTENSITY OF COMPETITIVE RIVALRY 91

5.7.3      BARGAINING POWER OF BUYERS           91

5.7.4      BARGAINING POWER OF SUPPLIERS     91

5.7.5      THREAT OF SUBSTITUTES         92

5.8         REGULATORY LANDSCAPE       92

5.8.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          92

TABLE 8             INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING ELECTROCEUTICALS MARKET      92

5.8.2      NORTH AMERICA          93

5.8.2.1   US         93

TABLE 9             US FDA: MEDICAL DEVICE CLASSIFICATION     93

TABLE 10           US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              93

5.8.2.2   Canada  94

TABLE 11           CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS           94

5.8.3      EUROPE             94

5.8.4      ASIA PACIFIC    94

5.8.4.1   China     94

TABLE 12           CHINA: CLASSIFICATION OF MEDICAL DEVICES             95

5.8.4.2   Japan     95

5.8.4.3   India      95

5.9         TECHNOLOGY ANALYSIS           96

5.10       TRADE ANALYSIS          97

5.10.1    IMPORT SCENARIO FOR PACEMAKERS 97

TABLE 13           IMPORT DATA FOR PACEMAKERS, BY COUNTRY, 2018–2022 (USD MILLION) 97

5.10.2    EXPORT SCENARIO FOR PACEMAKERS 98

TABLE 14           EXPORT DATA FOR PACEMAKERS, BY COUNTRY, 2018–2022 (USD MILLION) 98

5.10.3    IMPORT SCENARIO FOR COMPLIANT PRODUCTS          98

TABLE 15           IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)            98

5.10.4    EXPORT SCENARIO FOR COMPLIANT PRODUCTS          99

TABLE 16           EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)            99

5.11       PATENT ANALYSIS        99

FIGURE 24         ELECTROCEUTICALS MARKET: PATENT ANALYSIS OF CARDIAC PACEMAKERS             99

FIGURE 25         ELECTROCEUTICALS MARKET: PATENT ANALYSIS OF NEUROMODULATION PRODUCTS        100

5.12       KEY CONFERENCES AND EVENTS          100

TABLE 17           LIST OF CONFERENCES & EVENTS, 2024–2025    100

5.13       TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS     102

FIGURE 26         REVENUE SHIFT FOR ELECTROCEUTICALS MARKET     102

5.14       KEY STAKEHOLDERS AND BUYING CRITERIA    103

5.14.1    KEY STAKEHOLDERS IN BUYING PROCESS         103

FIGURE 27         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 103

TABLE 18           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER    103

5.14.2    BUYING CRITERIA         103

FIGURE 28         KEY BUYING CRITERIA FOR HOSPITALS             103

6            ELECTROCEUTICALS MARKET, BY PRODUCT   104

6.1         INTRODUCTION            105

TABLE 19           ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          105

6.2         CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS          105

6.2.1      INTRODUCTION OF LEADLESS AND MRI-SAFE PACEMAKERS & DEFIBRILLATORS TO BOOST MARKET GROWTH           105

TABLE 20           KEY PRODUCTS IN CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET      107

TABLE 21           CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2029 (USD MILLION)        108

TABLE 22           NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          108

TABLE 23           EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          109

TABLE 24           ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          109

TABLE 25           MIDDLE EAST & AFRICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2029 (USD MILLION)     110

6.3         COCHLEAR IMPLANTS 110

6.3.1      INCREASING PREVALENCE OF HEARING LOSS TO DRIVE DEMAND              110

TABLE 26           KEY PRODUCTS IN COCHLEAR IMPLANTS MARKET      111

TABLE 27           COCHLEAR IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION)          111

TABLE 28           NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    112

TABLE 29           EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     112

TABLE 30           ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          113

TABLE 31           MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION)       113

6.4         NEUROMODULATORS  113

TABLE 32           NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)          114

TABLE 33           NEUROMODULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)          114

TABLE 34           NORTH AMERICA: NEUROMODULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    115

TABLE 35           EUROPE: NEUROMODULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     115

TABLE 36           ASIA PACIFIC: NEUROMODULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          116

TABLE 37           MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)       116

6.4.1      SPINAL CORD STIMULATORS   116

6.4.1.1   Growing incidence of spinal cord injuries to support market growth        116

TABLE 38           KEY SPINAL CORD STIMULATOR DEVICES AVAILABLE IN MARKET            118

TABLE 39           SPINAL CORD STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 118

TABLE 40           NORTH AMERICA: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    119

TABLE 41          EUROPE: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          119

TABLE 42           ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    120

TABLE 43           MIDDLE EAST & AFRICA: SPINAL CORD STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)            120

6.4.2      DEEP BRAIN STIMULATORS      120

6.4.2.1   Widely used to control debilitating symptoms caused by movement and neurological disorders        120

TABLE 44           KEY DEEP BRAIN STIMULATOR DEVICES AVAILABLE IN MARKET            121

TABLE 45           DEEP BRAIN STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 122

TABLE 46           NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    122

TABLE 47           EUROPE: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          123

TABLE 48           ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    123

TABLE 49           MIDDLE EAST & AFRICA: DEEP BRAIN STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)  124

6.4.3      VAGUS NERVE STIMULATORS  124

6.4.3.1   High incidence of epilepsy to drive market     124

TABLE 50           KEY VAGUS NERVE STIMULATOR DEVICES AVAILABLE IN MARKET            124

TABLE 51           VAGUS NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 125

TABLE 52           NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    125

TABLE 53           EUROPE: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    126

TABLE 54           ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    126

TABLE 55           MIDDLE EAST & AFRICA: VAGUS NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)            127

6.4.4      SACRAL NERVE STIMULATORS 127

6.4.4.1   Widening scope of sacral nerve stimulation to drive growth        127

TABLE 56           KEY SACRAL NERVE STIMULATOR DEVICES AVAILABLE IN MARKET            128

TABLE 57           SACRAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 128

TABLE 58           NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    128

TABLE 59           EUROPE: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    129

TABLE 60           ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    129

TABLE 61           MIDDLE EAST & AFRICA: SACRAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)            130

6.4.5      GASTRIC ELECTRICAL STIMULATORS  130

6.4.5.1   Growing number of people suffering from severe GERD and gastroparesis to fuel market growth     130

TABLE 62           GASTRIC ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)          131

TABLE 63           NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         131

TABLE 64           EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    132

TABLE 65           ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)            132

TABLE 66           MIDDLE EAST & AFRICA: GASTRIC ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)            133

6.4.6      TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS            133

6.4.6.1   Extensive use in healthcare, low cost, and ease of use to favor market growth              133

TABLE 67           TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)            134

TABLE 68           NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         134

TABLE 69           EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         135

TABLE 70           ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         135

TABLE 71           MIDDLE EAST & AFRICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 136

6.4.7      TRANSCRANIAL MAGNETIC STIMULATORS       136

6.4.7.1   Minimal patient discomfort associated with TMS to support demand       136

TABLE 72           TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)       137

TABLE 73           NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         137

TABLE 74           EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)            138

TABLE 75           ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         138

TABLE 76           MIDDLE EAST & AFRICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)             139

6.4.8      RESPIRATORY ELECTRICAL STIMULATORS       139

6.4.8.1   Increasing incidence of spinal cord injuries to drive market        139

TABLE 77           RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)       140

TABLE 78           NORTH AMERICA: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         140

TABLE 79           EUROPE: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)            141

TABLE 80           ASIA PACIFIC: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         141

TABLE 81           MIDDLE EAST & AFRICA: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)             142

6.4.9      TRIGEMINAL NERVE STIMULATORS     142

6.4.9.1   High treatment efficacy to fuel market growth             142

TABLE 82           TRIGEMINAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)          142

TABLE 83           NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         143

TABLE 84           EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    143

TABLE 85           ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)            144

TABLE 86           MIDDLE EAST & AFRICA: TRIGEMINAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)            144

6.4.10    RESPONSIVE NEUROSTIMULATORS      144

6.4.10.1 Targeted and personalized treatment to fuel market growth       144

TABLE 87           RESPONSIVE NEUROSTIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)          145

TABLE 88           NORTH AMERICA: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         145

TABLE 89           EUROPE: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    146

TABLE 90           ASIA PACIFIC: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)            146

TABLE 91           MIDDLE EAST & AFRICA: RESPONSIVE NEUROSTIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)            147

6.5         RETINAL IMPLANTS      147

6.5.1      GROWING NUMBER OF RETINITIS PIGMENTOSA CASES TO SUPPORT MARKET GROWTH        147

TABLE 92           RETINAL IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION)          148

TABLE 93          NORTH AMERICA: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          148

TABLE 94           EUROPE: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     149

TABLE 95           ASIA PACIFIC: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          149

TABLE 96           MIDDLE EAST & AFRICA: RETINAL IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION)       150

7            ELECTROCEUTICALS MARKET, BY TYPE            151

7.1         INTRODUCTION            152

TABLE 97           ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)          152

7.2         IMPLANTABLE ELECTROCEUTICAL DEVICES    152

7.2.1      LONG-TERM COST SAVINGS TO DRIVE MARKET            152

TABLE 98           IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION)       154

TABLE 99           NORTH AMERICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)      154

TABLE 100         EUROPE: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         155

TABLE 101         ASIA PACIFIC: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         155

TABLE 102         MIDDLE EAST & AFRICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION)          156

7.3         NONINVASIVE ELECTROCEUTICAL DEVICES    156

7.3.1      EXTENSIVE USE IN HEALTHCARE, EASE OF USE, AND LOW COST TO SUPPORT MARKET GROWTH    156

TABLE 103         NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION)       157

TABLE 104         NORTH AMERICA: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)      158

TABLE 105         EUROPE: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         158

TABLE 106         ASIA PACIFIC: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)         159

TABLE 107         MIDDLE EAST & AFRICA: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION)          159

8            ELECTROCEUTICALS MARKET, BY APPLICATION          160

8.1         INTRODUCTION            161

8.2         ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), BY APPLICATION              161

TABLE 108         ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)     161

8.2.1      ARRHYTHMIA  161

8.2.1.1   Increasing prevalence of arrhythmia to support market growth  161

TABLE 109         CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY REGION, 2021–2029 (USD MILLION)          162

TABLE 110         NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021–2029 (USD MILLION)          162

TABLE 111         EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021–2029 (USD MILLION)          163

TABLE 112         ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021–2029 (USD MILLION)          163

8.2.2      HEART FAILURE            164

8.2.2.1   Rising prevalence of heart-related conditions in older individuals to drive growth              164

TABLE 113         CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY REGION, 2021–2029 (USD MILLION)          164

TABLE 114         NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021–2029 (USD MILLION)    165

TABLE 115         EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021–2029 (USD MILLION)    165

TABLE 116         ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021–2029 (USD MILLION)    166

8.2.3      OTHER CARDIAC PACEMAKER & ICD APPLICATIONS    166

TABLE 117         CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION) 167

TABLE 118         NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)    167

TABLE 119         EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)    168

TABLE 120         ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)    168

8.3         ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION  169

TABLE 121         ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     169

8.3.1      CHRONIC PAIN 169

8.3.1.1   High incidence of chronic pain to support market growth          169

TABLE 122         SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY REGION, 2021–2029 (USD MILLION)       170

TABLE 123         NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021–2029 (USD MILLION)           170

TABLE 124         EUROPE: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021–2029 (USD MILLION)           171

TABLE 125         ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021–2029 (USD MILLION)           171

8.3.2      FAILED BACK SURGERY SYNDROME      172

8.3.2.1   Increasing incidence of FBSS to drive demand             172

TABLE 126         SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2021–2029 (USD MILLION)   172

TABLE 127         NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021–2029 (USD MILLION)              173

TABLE 128         EUROPE: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021–2029 (USD MILLION)  173

TABLE 129         ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021–2029 (USD MILLION)              174

8.3.3      ISCHEMIA          174

8.3.3.1   High effectiveness of neuromodulation for ischemia treatment to propel market              174

TABLE 130         SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY REGION, 2021–2029 (USD MILLION)       175

TABLE 131         NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021–2029 (USD MILLION)      175

TABLE 132         EUROPE: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021–2029 (USD MILLION)      176

TABLE 133         ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021–2029 (USD MILLION)      176

8.4         ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION  177

TABLE 134         ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     177

8.4.1      PARKINSON’S DISEASE 177

8.4.1.1   Rising incidence of Parkinson’s disease and growing R&D to drive market              177

TABLE 135         DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY REGION, 2021–2029 (USD MILLION)             178

TABLE 136         NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2029 (USD MILLION)            178

TABLE 137         EUROPE: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2029 (USD MILLION)            179

TABLE 138         ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2029 (USD MILLION)            179

8.4.2      TREMORS          180

8.4.2.1   High efficacy of DBS in treating tremors to drive market           180

TABLE 139         DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY REGION, 2021–2029 (USD MILLION)       180

TABLE 140         NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021–2029 (USD MILLION)      180

TABLE 141         EUROPE: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021–2029 (USD MILLION)            181

TABLE 142         ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021–2029 (USD MILLION)      181

8.4.3      DEPRESSION    182

8.4.3.1   Rising research and clinical studies related to depression treatment to propel market   182

TABLE 143         DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2021–2029 (USD MILLION)       182

TABLE 144         NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION) 183

TABLE 145         EUROPE: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION) 183

TABLE 146         ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION) 184

8.4.4      OTHER DBS APPLICATIONS      184

TABLE 147         DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION) 185

TABLE 148         NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)           185

TABLE 149         EUROPE: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)           186

TABLE 150         ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)           186

8.5         ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION  187

TABLE 151         ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     187

8.5.1      URINE INCONTINENCE 187

8.5.1.1   High incidence of urine incontinence to offer growth opportunities for market players   187

TABLE 152         SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY REGION, 2021–2029 (USD MILLION)             188

TABLE 153         NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)  188

TABLE 154         EUROPE: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)         189

TABLE 155         ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)           189

8.5.2      FECAL INCONTINENCE 190

8.5.2.1   Reduced symptom recurrence with use of SNS to drive demand 190

TABLE 156         SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY REGION, 2021–2029 (USD MILLION)             190

TABLE 157         NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)  190

TABLE 158         EUROPE: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)         191

TABLE 159         ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)           191

8.6         ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION  192

TABLE 160         ELECTROCEUTICALS MARKET FOR VAGUS NERVE SIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)       192

8.6.1      EPILEPSY           192

8.6.1.1   Advantages associated with VNS in epilepsy treatment to propel market  192

TABLE 161         VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY REGION, 2021–2029 (USD MILLION)       192

TABLE 162         NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021–2029 (USD MILLION)       193

TABLE 163         EUROPE: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021–2029 (USD MILLION)       193

TABLE 164         ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021–2029 (USD MILLION)       194

8.6.2      OTHER VNS APPLICATIONS      194

TABLE 165         VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION) 194

TABLE 166         NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)           195

TABLE 167         EUROPE: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)           195

TABLE 168         ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)           196

8.7         ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION          196

TABLE 169         ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     196

8.7.1      GASTROPARESIS            197

8.7.1.1   Reduced hospitalization time associated with GES treatment to drive market              197

TABLE 170         GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY REGION, 2021–2029 (USD MILLION)            197

TABLE 171         NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021–2029 (USD MILLION)              197

TABLE 172         EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021–2029 (USD MILLION)        198

TABLE 173         ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021–2029 (USD MILLION) 198

8.7.2      OBESITY            199

8.7.2.1   High prevalence of obesity and risks associated with gastric bypass to propel market   199

TABLE 174         GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY REGION, 2021–2029 (USD MILLION)  199

TABLE 175         NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021–2029 (USD MILLION)            199

TABLE 176         EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021–2029 (USD MILLION)        200

TABLE 177         ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021–2029 (USD MILLION) 200

8.8         ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION           201

TABLE 178         ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          201

8.8.1      TREATMENT-RESISTANT DEPRESSION 201

8.8.1.1   High prevalence of depression to drive market             201

TABLE 179         TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY REGION, 2021–2029 (USD MILLION) 201

TABLE 180         NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)    202

TABLE 181         EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)    202

TABLE 182         ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)    203

8.8.2      OTHER TENS APPLICATIONS    203

TABLE 183         TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION)              203

TABLE 184         NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, 2021–2029 (USD MILLION)          204

TABLE 185         EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 204

TABLE 186         ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 205

8.9         ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION          205

TABLE 187         ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION              205

8.9.1      DEPRESSION    206

8.9.1.1   High effectiveness of TMS and increased acceptance among patients to drive market   206

TABLE 188         TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2021–2029 (USD MILLION)     206

TABLE 189         NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)    206

TABLE 190         EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)       207

TABLE 191         ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)    207

8.9.2      MIGRAINE         208

8.9.2.1   High prevalence of migraine to support market growth 208

TABLE 192         TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY REGION, 2021–2029 (USD MILLION)         208

TABLE 193         NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)         208

TABLE 194         EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)           209

TABLE 195         ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)         209

8.10       ELECTROCEUTICALS MARKET FOR RESPIRATORY ELECTRICAL STIMULATORS, BY APPLICATION          210

8.10.1    SPINAL CORD INJURY   210

8.10.1.1 Rising incidence of spinal cord injuries to fuel demand 210

TABLE 196         RESPIRATORY ELECTRICAL STIMULATORS MARKET FOR SPINAL CORD INJURY, BY REGION, 2021–2029 (USD MILLION)   210

8.11       ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION          211

TABLE 197         ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION      211

8.11.1    ATTENTION-DEFICIT/HYPERACTIVITY DISORDER        211

8.11.1.1 Minimal side effects to drive adoption           211

TABLE 198         TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY REGION, 2021–2029 (USD MILLION) 212

TABLE 199         NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021–2029 (USD MILLION)    212

TABLE 200         EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021–2029 (USD MILLION) 213

TABLE 201         ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021–2029 (USD MILLION)     213

8.11.2    MIGRAINE         214

8.11.2.1 Increasing demand for non-pharmacological treatments to support market growth              214

TABLE 202         TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY REGION, 2021–2029 (USD MILLION)  214

TABLE 203         NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)         215

TABLE 204         EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)     215

TABLE 205         ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)           216

9            ELECTROCEUTICALS MARKET, BY REGION       217

9.1         INTRODUCTION            218

TABLE 206         ELECTROCEUTICALS MARKET, BY REGION, 2021–2029 (USD MILLION)          218

9.2         NORTH AMERICA          218

FIGURE 29         NORTH AMERICA: ELECTROCEUTICALS MARKET SNAPSHOT              219

TABLE 207         NORTH AMERICA: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    220

TABLE 208         NORTH AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)   220

TABLE 209         NORTH AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)          221

TABLE 210         NORTH AMERICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)          221

TABLE 211         NORTH AMERICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)     222

TABLE 212         NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)       222

TABLE 213         NORTH AMERICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      223

TABLE 214         NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      223

TABLE 215         NORTH AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      223

TABLE 216         NORTH AMERICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          224

TABLE 217         NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          224

TABLE 218         NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          224

TABLE 219         NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          225

9.2.1      US         225

9.2.1.1   Rising prevalence of cardiovascular and neurological disorders to drive market              225

TABLE 220         US: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 227

TABLE 221         US: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)          227

TABLE 222         US: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)          228

TABLE 223         US: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)           228

TABLE 224         US: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     229

TABLE 225         US: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     229

TABLE 226         US: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     230

TABLE 227         US: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     230

TABLE 228         US: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     230

TABLE 229         US: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          231

TABLE 230         US: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              231

TABLE 231         US: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     231

9.2.2      CANADA            232

9.2.2.1   Rising healthcare expenditure and increasing prevalence of chronic diseases to drive demand       232

TABLE 232         NEUROLOGICAL CONDITIONS PREVALENT IN CANADA, 2016–2031      232

TABLE 233         CANADA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     233

TABLE 234         CANADA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 234

TABLE 235         CANADA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 234

TABLE 236         CANADA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)           235

TABLE 237         CANADA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     235

TABLE 238         CANADA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     236

TABLE 239         CANADA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     236

TABLE 240         CANADA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     236

TABLE 241         CANADA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              237

TABLE 242         CANADA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          237

TABLE 243         CANADA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              237

TABLE 244         CANADA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      238

9.2.3      NORTH AMERICA: RECESSION IMPACT 238

9.3         EUROPE             238

TABLE 245         EUROPE: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     239

TABLE 246         EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     239

TABLE 247         EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 240

TABLE 248         EUROPE: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 240

TABLE 249         EUROPE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)           241

TABLE 250         EUROPE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     241

TABLE 251         EUROPE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     242

TABLE 252         EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     242

TABLE 253         EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     242

TABLE 254         EUROPE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              243

TABLE 255         EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          243

TABLE 256         EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              243

TABLE 257         EUROPE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      244

9.3.1      GERMANY         244

9.3.1.1   Presence of favorable reimbursement policies to drive market    244

TABLE 258         GERMANY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          245

TABLE 259         GERMANY: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)     245

TABLE 260         GERMANY: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 246

TABLE 261         GERMANY: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)           246

TABLE 262         GERMANY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     247

TABLE 263         GERMANY: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     247

TABLE 264         GERMANY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     248

TABLE 265         GERMANY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     248

TABLE 266         GERMANY: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              248

TABLE 267         GERMANY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          249

TABLE 268         GERMANY: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          249

TABLE 269         GERMANY: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      249

9.3.2      UK         250

9.3.2.1   Rising support from government and private organizations to fuel market growth              250

TABLE 270         UK: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 251

TABLE 271         UK: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)          251

TABLE 272         UK: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)          252

TABLE 273         UK: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)           252

TABLE 274         UK: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     253

TABLE 275         UK: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     253

TABLE 276         UK: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     254

TABLE 277         UK: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     254

TABLE 278         UK: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     254

TABLE 279         UK: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          255

TABLE 280         UK: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              255

TABLE 281         UK: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     255

9.3.3      FRANCE             256

9.3.3.1   Promising healthcare reforms to drive market 256

TABLE 282         FRANCE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     256

TABLE 283         FRANCE: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 257

TABLE 284         FRANCE: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 257

TABLE 285         FRANCE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)           258

TABLE 286         FRANCE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     258

TABLE 287         FRANCE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     259

TABLE 288         FRANCE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     259

TABLE 289         FRANCE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     259

TABLE 290         FRANCE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              260

TABLE 291         FRANCE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          260

TABLE 292         FRANCE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              260

TABLE 293         FRANCE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      261

9.3.4      ITALY   261

9.3.4.1   Easy access to healthcare services to create lucrative opportunities for market growth   261

TABLE 294         ITALY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     262

TABLE 295         ITALY: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 263

TABLE 296         ITALY: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 263

TABLE 297         ITALY: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)           264

TABLE 298         ITALY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     264

TABLE 299         ITALY: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     265

TABLE 300         ITALY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     265

TABLE 301         ITALY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     265

TABLE 302         ITALY: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              266

TABLE 303         ITALY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          266

TABLE 304         ITALY: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              266

TABLE 305         ITALY: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      267

9.3.5      SPAIN   267

9.3.5.1   Increasing number of conferences and awareness programs to support market growth   267

TABLE 306         SPAIN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     268

TABLE 307         SPAIN: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 268

TABLE 308         SPAIN: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 269

TABLE 309         SPAIN: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)           269

TABLE 310         SPAIN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     269

TABLE 311         SPAIN: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     270

TABLE 312         SPAIN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     270

TABLE 313         SPAIN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     270

TABLE 314         SPAIN: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              271

TABLE 315         SPAIN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          271

TABLE 316         SPAIN: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              271

TABLE 317         SPAIN: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      272

9.3.6      REST OF EUROPE           272

TABLE 318         REST OF EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)   273

TABLE 319         REST OF EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)          273

TABLE 320         REST OF EUROPE: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)          274

TABLE 321         REST OF EUROPE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)     274

TABLE 322         REST OF EUROPE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)       275

TABLE 323         REST OF EUROPE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      275

TABLE 324         REST OF EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      276

TABLE 325         REST OF EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      276

TABLE 326         REST OF EUROPE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          276

TABLE 327         REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          277

TABLE 328         REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          277

TABLE 329         REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          278

9.3.7      EUROPE: RECESSION IMPACT   278

9.4         ASIA PACIFIC    278

FIGURE 30         ASIA PACIFIC: ELECTROCEUTICALS MARKET SNAPSHOT              279

TABLE 330         ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          280

TABLE 331         ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          280

TABLE 332         ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)     281

TABLE 333         ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)     281

TABLE 334         ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)           282

TABLE 335         ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)       282

TABLE 336         ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     283

TABLE 337         ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      283

TABLE 338         ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      283

TABLE 339         ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              284

TABLE 340         ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          284

TABLE 341         ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          284

TABLE 342         ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          285

9.4.1      JAPAN  285

9.4.1.1   Increasing prevalence of cardiovascular and neurological disorders to drive demand 285

TABLE 343         JAPAN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     286

TABLE 344         JAPAN: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 287

TABLE 345         JAPAN: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 287

TABLE 346         JAPAN: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)           288

TABLE 347         JAPAN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     288

TABLE 348         JAPAN: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     289

TABLE 349         JAPAN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     289

TABLE 350         JAPAN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     290

TABLE 351         JAPAN: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              290

TABLE 352         JAPAN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          290

TABLE 353         JAPAN: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              291

TABLE 354         JAPAN: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      291

9.4.2      CHINA  291

9.4.2.1   Rising geriatric population to support market growth   291

TABLE 355         CHINA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     292

TABLE 356         CHINA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 293

TABLE 357         CHINA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 293

TABLE 358         CHINA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)           294

TABLE 359         CHINA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     294

TABLE 360         CHINA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     295

TABLE 361         CHINA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     295

TABLE 362         CHINA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     296

TABLE 363         CHINA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              296

TABLE 364         CHINA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          296

TABLE 365         CHINA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              297

TABLE 366         CHINA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      297

9.4.3      INDIA   297

9.4.3.1   Developments in healthcare structure to propel market             297

TABLE 367         INDIA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 298

TABLE 368         INDIA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 299

TABLE 369         INDIA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION) 299

TABLE 370         INDIA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)           300

TABLE 371         INDIA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     300

TABLE 372         INDIA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     301

TABLE 373         INDIA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     301

TABLE 374         INDIA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)     301

TABLE 375         INDIA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              302

TABLE 376         INDIA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          302

TABLE 377         INDIA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              302

TABLE 378         INDIA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      303

9.4.4      REST OF ASIA PACIFIC  303

TABLE 379         REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)   304

TABLE 380         REST OF ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)             304

TABLE 381         REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)             305

TABLE 382         REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)     305

TABLE 383         REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              306

TABLE 384         REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              306

TABLE 385         REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              307

TABLE 386         REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              307

TABLE 387         REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          307

TABLE 388         REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          308

TABLE 389         REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          308

TABLE 390         REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          308

9.4.5      ASIA PACIFIC: RECESSION IMPACT        309

9.5         LATIN AMERICA             309

9.5.1      RAPIDLY GROWING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH          309

TABLE 391        LATIN AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          310

TABLE 392         LATIN AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)          311

TABLE 393         LATIN AMERICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)          311

TABLE 394         LATIN AMERICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)           312

TABLE 395         LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)       312

TABLE 396         LATIN AMERICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      313

TABLE 397         LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      313

TABLE 398         LATIN AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)      313

TABLE 399         LATIN AMERICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              314

TABLE 400         LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          314

TABLE 401         LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          314

TABLE 402         LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          315

9.5.2      LATIN AMERICA: RECESSION IMPACT   315

9.6         MIDDLE EAST & AFRICA             315

TABLE 403         MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY REGION, 2021–2029 (USD MILLION)       316

TABLE 404         MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)   316

TABLE 405         MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)             317

TABLE 406         MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)             317

TABLE 407         MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)     318

TABLE 408         MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              318

TABLE 409         MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              319

TABLE 410         MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              319

TABLE 411         MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)              319

TABLE 412         MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          320

TABLE 413         MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          320

TABLE 414         MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          320

TABLE 415         MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)          321

9.6.1      GCC COUNTRIES           321

9.6.1.1   Advances in healthcare sector to support market growth            321

TABLE 416         GCC COUNTRIES: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)   322

TABLE 417         GCC COUNTRIES: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)          322

TABLE 418         GCC COUNTRIES: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)          323

9.6.2      REST OF MIDDLE EAST & AFRICA           323

TABLE 419         REST OF MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)        324

TABLE 420         REST OF MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)    324

TABLE 421         REST OF MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)    325

9.6.3      MIDDLE EAST & AFRICA: RECESSION IMPACT   325

10          COMPETITIVE LANDSCAPE       326

10.1       OVERVIEW        326

10.2       STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN           326

TABLE 422         OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS              326

10.3       REVENUE ANALYSIS      328

FIGURE 31         REVENUE ANALYSIS OF KEY PLAYERS IN ELECTROCEUTICALS MARKET            328

10.4       MARKET SHARE ANALYSIS         328

TABLE 423         ELECTROCEUTICALS MARKET: DEGREE OF COMPETITION              329

10.5       BRAND/PRODUCT COMPARISON          330

FIGURE 32         ELECTROCEUTICALS MARKET: BRAND COMPARISON, BY KEY PLAYER 330

10.6       COMPANY EVALUATION MATRIX: KEY PLAYERS            330

10.6.1    STARS  330

10.6.2    EMERGING LEADERS    330

10.6.3    PERVASIVE PLAYERS     331

10.6.4    PARTICIPANTS 331

FIGURE 33         ELECTROCEUTICALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022    331

10.7       COMPANY FOOTPRINT 332

TABLE 424         PRODUCT FOOTPRINT 332

TABLE 425         REGIONAL FOOTPRINT             333

TABLE 426         OVERALL COMPANY FOOTPRINT          334

10.8       COMPANY EVALUATION MATRIX: STARTUPS/SMES      334

10.8.1    PROGRESSIVE COMPANIES       334

10.8.2    STARTING BLOCKS       334

10.8.3    RESPONSIVE COMPANIES          335

10.8.4    DYNAMIC COMPANIES 335

FIGURE 34         ELECTROCEUTICALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/ SMES), 2022           335

10.9       COMPETITIVE BENCHMARKING            336

TABLE 427         ELECTROCEUTICALS MARKET: DETAILED LIST OF KEY STARTUPS/SMES           336

TABLE 428         PRODUCT FOOTPRINT (STARTUPS/SMES)        337

TABLE 429         REGIONAL FOOTPRINT (STARTUPS/SMES)       337

TABLE 430         OVERALL COMPANY FOOTPRINT (STARTUPS/SMES)    338

10.10     COMPETITIVE SCENARIO          338

10.10.1  PRODUCT LAUNCHES & APPROVALS    338

TABLE 431         PRODUCT LAUNCHES & APPROVALS    338

10.10.2  DEALS  340

TABLE 432         DEALS  340

11          COMPANY PROFILES    341

(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*

11.1       KEY PLAYERS   341

11.1.1    MEDTRONIC     341

TABLE 433         MEDTRONIC: BUSINESS OVERVIEW       341

FIGURE 35         MEDTRONIC: COMPANY SNAPSHOT (2023)       342

11.1.2    BOSTON SCIENTIFIC CORPORATION    347

TABLE 434         BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW              347

FIGURE 36         BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)   348

11.1.3    ABBOTT            352

TABLE 435         ABBOTT: BUSINESS OVERVIEW 352

FIGURE 37         ABBOTT: COMPANY SNAPSHOT (2022) 353

11.1.4    LIVANOVA PLC 357

TABLE 436         LIVANOVA PLC: BUSINESS OVERVIEW  357

FIGURE 38         LIVANOVA PLC: COMPANY SNAPSHOT (2022)   358

11.1.5    COCHLEAR LTD.            360

TABLE 437         COCHLEAR LTD.: BUSINESS OVERVIEW 360

FIGURE 39         COCHLEAR LTD.: COMPANY SNAPSHOT (2023) 361

11.1.6    MICROPORT SCIENTIFIC CORPORATION           363

TABLE 438         MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW        363

FIGURE 40         MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)          364

11.1.7    SONOVA            367

TABLE 439         SONOVA: BUSINESS OVERVIEW 367

FIGURE 41         SONOVA GROUP: COMPANY SNAPSHOT (2022) 368

11.1.8    NEVRO CORP.   370

TABLE 440         NEVRO CORP.: BUSINESS OVERVIEW     370

FIGURE 42         NEVRO CORP.: COMPANY SNAPSHOT (2022)     370

11.1.9    AXONICS, INC.  372

TABLE 441         AXONICS, INC.: BUSINESS OVERVIEW    372

FIGURE 43         AXONICS INC.: COMPANY SNAPSHOT (2022)     372

11.1.10  NEURONETICS 374

TABLE 442         NEURONETICS: BUSINESS OVERVIEW   374

FIGURE 44         NEURONETICS: COMPANY SNAPSHOT (2022)    375

11.1.11  ELECTROCORE, INC.     377

TABLE 443         ELECTROCORE, INC.: BUSINESS OVERVIEW       377

FIGURE 45         ELECTROCORE, INC.: COMPANY SNAPSHOT (2022)       377

11.1.12  NEUROPACE, INC.         379

TABLE 444         NEUROPACE, INC.: BUSINESS OVERVIEW           379

FIGURE 46         NEUROPACE, INC.: COMPANY SNAPSHOT (2022)            379

11.2       OTHER PLAYERS           381

11.2.1    BIOTRONIK       381

TABLE 445         BIOTRONIK: COMPANY OVERVIEW       381

11.2.2    MEDICO S.R.L.  383

TABLE 446         MEDICO S.R.L.: COMPANY OVERVIEW   383

11.2.3    ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.     384

TABLE 447         ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW  384

11.2.4    MED-EL             385

TABLE 448         MED-EL: COMPANY OVERVIEW 385

11.2.5    ALEVA NEUROTHERAPEUTICS 385

TABLE 449         ALEVA NEUROTHERAPEUTICS: COMPANY OVERVIEW  385

11.2.6    NEUROSIGMA, INC.       386

TABLE 450         NEUROSIGMA, INC.: COMPANY OVERVIEW        386

11.2.7    BIOWAVE CORPORATION          387

TABLE 451         BIOWAVE CORPORATION: COMPANY OVERVIEW          387

11.2.8    SOTERIX MEDICAL INC.              388

TABLE 452         SOTERIX MEDICAL INC.: COMPANY OVERVIEW 388

11.2.9    BIOINDUCTION (AMBER THERAPEUTICS)         388

TABLE 453         BIOINDUCTION (AMBER THERAPEUTICS): COMPANY OVERVIEW        388

11.2.10  GIMER MEDICAL           389

TABLE 454         GIMER MEDICAL: COMPANY OVERVIEW            389

11.2.11  CEFALY 389

TABLE 455         CEFALY: COMPANY OVERVIEW 389

11.2.12  BIOCONTROL MEDICAL            390

TABLE 456         BIOCONTROL MEDICAL: COMPANY OVERVIEW             390

11.2.13  TVNS HEALTH GMBH   390

TABLE 457         TVNS HEALTH GMBH: COMPANY OVERVIEW    390

*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.

12          APPENDIX         391

12.1       DISCUSSION GUIDE      391

12.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             396

12.3       CUSTOMIZATION OPTIONS      398

12.4       RELATED REPORTS       399

12.5       AUTHOR DETAILS         400